Rolf Wolfgang Hartmann

Title: Rolf Wolfgang Hartmann: Innovator in Pharmaceutical Research

Introduction

Rolf Wolfgang Hartmann is a notable inventor based in Saarbrücken, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds aimed at treating bacterial infections. With a total of 17 patents to his name, Hartmann's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Hartmann has developed PqsR inverse agonists. This invention relates to a compound that acts as an inhibitor of PqsR, the only known receptor for the Quinolone Signal (PQS). The patent also includes a pharmaceutical composition containing this compound, as well as a combination preparation with at least one further active pharmaceutical ingredient. The uses of these compounds include their application as medicaments for the treatment or prophylaxis of bacterial infections. Another significant patent is for cystobactamides, which are compounds designed for the treatment or prophylaxis of bacterial infections.

Career Highlights

Hartmann has worked with several prominent companies in the pharmaceutical sector. Notably, he has been associated with Elexopharm GmbH and Helmholtz-Zentrum für Infektionsforschung GmbH. His work in these organizations has allowed him to advance his research and contribute to innovative solutions in the field of medicine.

Collaborations

Throughout his career, Hartmann has collaborated with esteemed colleagues, including Ralf Heim and Qingzhong Hu. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his research.

Conclusion

Rolf Wolfgang Hartmann is a distinguished inventor whose work in pharmaceutical research has led to significant advancements in the treatment of bacterial infections. His numerous patents and collaborations reflect his commitment to innovation and excellence in the field.